Mpex Pharmaceuticals Signs Agreement With Mixture Sciences, Inc. 
10/19/2005 5:08:53 PM

Mpex Pharmaceuticals, Inc. ("Mpex") and Mixture Sciences, Inc. ("Mixture") announced today that they have entered into a research collaboration that utilizes Mixture's combinatorial libraries to identify novel lead compounds appropriate for antibacterial development by Mpex. Mpex is pursuing the discovery of new broad-spectrum antibiotics that meet the growing clinical need created by multi-drug resistant bacterial pathogens.